Navigation Links
Questcor Pharmaceuticals to Present at Jefferies 2012 Global Healthcare Conference
Date:5/24/2012

ANAHEIM, Calif., May 24, 2012 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) announced today that executive management will present at the Jefferies 2012 Global Healthcare Conference in New York on June 6, 2012 at 5:00 a.m. PT / 8:00 a.m. ET.

A live webcast and subsequent archived replay of the presentation will be accessible at http://ir.questcor.com/events.cfm.  The replay will be available for approximately 90 days after the event.

About Questcor

Questcor Pharmaceuticals, Inc. is a biopharmaceutical company whose primary product helps patients with serious, difficult-to-treat medical conditions.  Questcor's primary product is H.P. Acthar® Gel (repository corticotropin injection), an injectable drug that is approved by the FDA for the treatment of 19 indications.  Of these 19 indications, Questcor currently generates substantially all of its net sales from three indications: the treatment of proteinuria in idiopathic types of nephrotic syndrome, the treatment of acute exacerbations of multiple sclerosis in adults, and the treatment of infantile spasms in children under two years of age. With respect to nephrotic syndrome, the FDA has approved Acthar to "induce a diuresis or a remission of proteinuria in the nephrotic syndrome without uremia of the idiopathic type or that due to lupus erythematosus."  Questcor is also currently preparing to launch a pilot effort in rheumatology, as Acthar is approved for several rheumatology-related conditions including Lupus, Dermatomyositis, Polymyositis and Rheumatoid Arthritis. Questcor is also exploring the possibility of developing markets for other on-label indications and the possibility of pursuing FDA approval of additional indications not currently on the Acthar label where there is high unmet medical need.    For more information about Questcor, please visit www.questcor.com.  


'/>"/>
SOURCE Questcor Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Questcor Pharmaceuticals Expands Repurchase Program
2. Questcor Pharmaceuticals to Present at the Leerink Swann Global Healthcare Conference on February 16, 2012
3. Questcor Pharmaceuticals to Present at the Oppenheimer Healthcare Conference on December 13, 2011
4. Questcor Pharmaceuticals to Present at Upcoming Investor Conferences in September
5. Questcor Pharmaceuticals to Present at the Jefferies Global Healthcare Conference on June 9, 2011
6. Questcor Pharmaceuticals to Be Added to S&P SmallCap 600 Index
7. Questcor Announces Third Quarter 2010 Earnings Release Date and Conference Call
8. Eutropics Pharmaceuticals Receives U.S. Patent for Novel Diagnostic Method
9. Silence Therapeutics Partner, Quark Pharmaceuticals, Extends its Agreement With Pfizer to Develop one of Its Compounds Containing Silences AtuRNAi in a New Indication
10. Cadence Pharmaceuticals To Present At The Deutsche Bank Securities, Inc. 37th Annual Health Care Conference In Boston On May 8, 2012
11. Syndax Pharmaceuticals Appoints Arlene Morris as CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2017)... (PRWEB) , ... May 16, 2017 , ... ... and Trademark Office (USPTO) for a wireless electrocardiogram (ECG or EKG) acquisition and ... to be integrated into clothing, or secured directly onto the skin, making them ...
(Date:5/16/2017)... YORK , May 16, 2017 ... many healthcare organizations and something that has been ... record (EHR) optimization. But according to   Logicalis ... US, an international IT solutions and managed services ... – and often overlooked – interrelationship between telehealth, ...
(Date:5/16/2017)... MA (PRWEB) , ... May 16, 2017 , ... On ... have an ideal audience for introducing the advance in stem cell medicine that his ... Tuesday will be the second day of the Alliance for Regenerative Medicine’s first partnering ...
(Date:5/15/2017)... Somerset, N.J. (PRWEB) , ... May 15, 2017 ... ... advanced delivery technologies and development solutions for drugs, biologics and consumer health products, ... biotechnology company focused on rare genetic diseases, to support preclinical and clinical development ...
Breaking Biology Technology:
(Date:5/16/2017)... , May 16, 2017   Bridge ... health organizations, and MD EMR Systems , ... development partner for GE, have established a partnership ... Portal product and the GE Centricity™ products, including ... EMR. These new integrations will ...
(Date:4/19/2017)... York , April 19, 2017 ... as its vendor landscape is marked by the presence ... market is however held by five major players - ... Together these companies accounted for nearly 61% of the ... the leading companies in the global military biometrics market ...
(Date:4/13/2017)... , April 13, 2017 UBM,s Advanced ... will feature emerging and evolving technology through ... Innovation Summits will run alongside the expo portion of ... sessions, panels and demonstrations focused on trending topics within ... advanced design and manufacturing event will take place June ...
Breaking Biology News(10 mins):